Search clinical trials for: ZW25 (Zanidatamab)
Total 18 results
-
Jazz PharmaceuticalsAvailableHER2-Positive Advanced Biliary Tract CancerSpain, United States, France, Italy, United Kingdom
-
Jazz PharmaceuticalsALX Oncology Inc.RecruitingHER2-expressing CancersUnited States
-
Jazz PharmaceuticalsBeiGene, Ltd.Active, not recruitingHER2-amplified Biliary Tract CancersUnited States, Spain, United Kingdom, Korea, Republic of, Canada, China, Italy, Chile, France
-
Memorial Sloan Kettering Cancer CenterZymeworks BC Inc.Completed
-
Jazz PharmaceuticalsRecruitingBiliary Tract Cancer | HER2 Gene MutationUnited States, Puerto Rico
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of
-
Yonsei UniversityNot yet recruitingHER2-positive Gastric CancerKorea, Republic of
-
Jazz PharmaceuticalsBeiGene, Ltd.RecruitingGastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric NeoplasmsKorea, Republic of, Belgium, Netherlands, Spain, Japan, China, Germany, United Kingdom, Malaysia, Taiwan, Portugal, France, Italy, Australia, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Singapore, Poland and more
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
M.D. Anderson Cancer CenterZymeworks Inc.Active, not recruitingBreast Cancer | HER2-positiveUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerUnited States, Korea, Republic of, Chile, Canada
-
Canadian Cancer Trials GroupJazz PharmaceuticalsNot yet recruitingGastroesophageal Adenocarcinoma
-
Clavis PharmaCompletedNot Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy SubjectsUnited Kingdom
-
BeiGeneActive, not recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction CancerChina, Taiwan, Korea, Republic of
-
Guy's and St Thomas' NHS Foundation TrustMonash University; Australian and New Zealand Intensive Care Research Centre; Royal Surrey County Hospital NHS Foundation TrustRecruitingCOVID | Acute Respiratory Distress SyndromeUnited Kingdom
-
UNICANCERCancer Research UK; National Cancer Institute, France; Servier; Pierre Fabre Medicament and other collaboratorsNot yet recruitingBiliary Tract NeoplasmsUnited Kingdom, France, Belgium
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States